NEW YORK, June 21, 2016 /PRNewswire/ — Centinel Spine, Inc., (Centinel Spine), the pioneer of the No-Profile®, Integrated Interbody™ fusion device market, completes Alpha release of STALIF L™ No-Profile, lateral lumbar Integrated Interbody device cleared by the U.S. Food and Drug Administration (FDA). STALIF L continues the thirty-year STALIF® heritage of innovation as STALIF L […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone